Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

NCT04290793 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pyrotinib
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Taxanes
BIOLOGICAL: Trastuzumab

Sponsor

Hebei Medical University Fourth Hospital